Soviets Seek To Rebuild Labs, Renew Ties To West

It's party time for United States-Soviet scientific relations, as perestroika lifts the curtains of the Cold War. In recent months, so many scientists have traveled between the two countries that Soviet-watchers have lost count of the numbers. The words "joint venture" are on everyone's lips, as researchers-turned-entrepreneurs struggle to market Soviet scientific know-how to the world. But these cheerful developments are haunted by the USSR's worsening economic woes, which have made it increa

Written byKeay Davidson
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

It's party time for United States-Soviet scientific relations, as perestroika lifts the curtains of the Cold War. In recent months, so many scientists have traveled between the two countries that Soviet-watchers have lost count of the numbers. The words "joint venture" are on everyone's lips, as researchers-turned-entrepreneurs struggle to market Soviet scientific know-how to the world.

But these cheerful developments are haunted by the USSR's worsening economic woes, which have made it increasingly difficult in the last few years for Soviet researchers to obtain basic scientific gear ranging from chemical reagents to restriction enzymes - not to mention fancy Western computers and copying machines.

The opening of the Soviet market has meant a rush of high-tech joint ventures, in which U.S. and Soviet entrepreneurs undertake common profit-making businesses. In November BIOS Corp. a New Haven, Conn., biotech firm, signed a tentative agreement with the Soviet Ministry of Health to start ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies